Feifei Su

1.3k total citations
36 papers, 738 citations indexed

About

Feifei Su is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Feifei Su has authored 36 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 11 papers in Molecular Biology and 7 papers in Infectious Diseases. Recurrent topics in Feifei Su's work include Cardiac electrophysiology and arrhythmias (5 papers), Cardiac Fibrosis and Remodeling (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Feifei Su is often cited by papers focused on Cardiac electrophysiology and arrhythmias (5 papers), Cardiac Fibrosis and Remodeling (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Feifei Su collaborates with scholars based in China, United States and Australia. Feifei Su's co-authors include Chenchan Hu, Jianyi Dai, Jianping Huang, Qifa Song, Chen Dong, Xiaoming Zhang, Xiaokun Li, Jian Zhang, Hongtao Wang and Jie Qi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Feifei Su

33 papers receiving 722 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feifei Su China 14 264 206 169 109 89 36 738
Francesca Fortini Italy 19 240 0.9× 168 0.8× 153 0.9× 81 0.7× 110 1.2× 37 877
Nikolaos I. Vlachogiannis Greece 19 403 1.5× 162 0.8× 135 0.8× 196 1.8× 55 0.6× 47 1.0k
Sina M. Coldewey Germany 19 372 1.4× 113 0.5× 108 0.6× 229 2.1× 78 0.9× 57 1.0k
Chunlei Zhang China 16 212 0.8× 88 0.4× 92 0.5× 105 1.0× 42 0.5× 61 757
Margaret Zhou United States 10 270 1.0× 98 0.5× 61 0.4× 88 0.8× 50 0.6× 28 700
Angela Cozma Romania 15 184 0.7× 49 0.2× 134 0.8× 136 1.2× 44 0.5× 85 747
Theo Nell South Africa 17 223 0.8× 80 0.4× 71 0.4× 131 1.2× 81 0.9× 32 783
Rui Tian China 20 388 1.5× 113 0.5× 77 0.5× 272 2.5× 71 0.8× 57 1.2k
Su Wang China 14 394 1.5× 159 0.8× 257 1.5× 86 0.8× 16 0.2× 39 994
Juqian Zhang China 15 147 0.6× 70 0.3× 352 2.1× 77 0.7× 40 0.4× 40 912

Countries citing papers authored by Feifei Su

Since Specialization
Citations

This map shows the geographic impact of Feifei Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Su more than expected).

Fields of papers citing papers by Feifei Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feifei Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Su. The network helps show where Feifei Su may publish in the future.

Co-authorship network of co-authors of Feifei Su

This figure shows the co-authorship network connecting the top 25 collaborators of Feifei Su. A scholar is included among the top collaborators of Feifei Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feifei Su. Feifei Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhu, Xingyu, et al.. (2024). An interpretable machine learning method for risk stratification of patients with acute coronary syndrome. Heliyon. 10(17). e36815–e36815. 1 indexed citations
3.
Zhu, Jiawei, An‐Li Wang, Hui Ye, et al.. (2023). Harnessing gradient gelatin nanocomposite hydrogels: a progressive approach to tackling antibacterial biofilms. RSC Advances. 13(43). 30453–30461. 3 indexed citations
4.
5.
6.
Shi, Yi, Shuo Pan, Hui Ye, et al.. (2023). The diagnosis of tuberculous meningitis: advancements in new technologies and machine learning algorithms. Frontiers in Microbiology. 14. 1290746–1290746. 10 indexed citations
7.
Su, Feifei, et al.. (2022). Disseminated talaromycosis complicated by recurrent gastrointestinal bleeding and hemorrhagic shock: a case report. BMC Infectious Diseases. 22(1). 238–238. 3 indexed citations
8.
9.
Jin, Lingling, et al.. (2019). SNHG20 knockdown suppresses proliferation, migration and invasion, and promotes apoptosis in non-small cell lung cancer through acting as a miR-154 sponge. Biomedicine & Pharmacotherapy. 112. 108648–108648. 25 indexed citations
10.
11.
Su, Feifei, Jian Zhang, Qiangsun Zheng, et al.. (2018). Simvastatin Protects Heart from Pressure Overload Injury by Inhibiting Excessive Autophagy. International Journal of Medical Sciences. 15(13). 1508–1516. 19 indexed citations
12.
Knezevic, Tijana, Valerie D. Myers, Feifei Su, et al.. (2016). Adeno-Associated Virus Serotype 9–Driven Expression of BAG3 Improves Left Ventricular Function in Murine Hearts With Left Ventricular Dysfunction Secondary to a Myocardial Infarction. JACC Basic to Translational Science. 1(7). 647–656. 37 indexed citations
13.
Su, Feifei, Xiongtao Liu, Hongtao Wang, et al.. (2016). Cilostazol suppresses angiotensin II-induced apoptosis in endothelial cells. Molecular Medicine Reports. 13(3). 2597–2605. 10 indexed citations
14.
Feldman, Arthur M., Jennifer Gordon, JuFang Wang, et al.. (2016). BAG3 regulates contractility and Ca2+ homeostasis in adult mouse ventricular myocytes. Journal of Molecular and Cellular Cardiology. 92. 10–20. 52 indexed citations
15.
Hay, Iain D., David R. Cameron, Mary Speir, et al.. (2015). Antibiotic regimen based on population analysis of residing persister cells eradicates Staphylococcus epidermidis biofilms. Scientific Reports. 5(1). 18578–18578. 34 indexed citations
16.
17.
Zeng, Di, Yan Jin, Xiongtao Liu, et al.. (2013). The Long-Term Differentiation of Embryonic Stem Cells into Cardiomyocytes: An Indirect Co-Culture Model. PLoS ONE. 8(1). e55233–e55233. 13 indexed citations
18.
Su, Feifei, et al.. (2012). Simvastatin Modulates Remodeling of Kv4.3 Expression in Rat Hypertrophied Cardiomyocytes. International Journal of Biological Sciences. 8(2). 236–248. 7 indexed citations
19.
Fu, Guoqiang, Jun Lü, Jun Li, et al.. (2012). Programmed cell death-1 deficiency results in atrial remodeling in C57BL/6 mice. International Journal of Molecular Medicine. 31(2). 423–429. 13 indexed citations
20.
Guo, Wangang, Feifei Su, Lijun Yuan, et al.. (2009). Simvastatin inhibits angiotensin II‐induced cardiac cell hypertrophy: Role of Homer 1a. Clinical and Experimental Pharmacology and Physiology. 37(1). 40–45. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Fortini Breakdown of academic impact, for papers by Nikolaos I. Vlachogiannis Breakdown of academic impact, for papers by Sina M. Coldewey Breakdown of academic impact, for papers by Chunlei Zhang Breakdown of academic impact, for papers by Margaret Zhou Breakdown of academic impact, for papers by Angela Cozma Breakdown of academic impact, for papers by Theo Nell Breakdown of academic impact, for papers by Rui Tian Breakdown of academic impact, for papers by Su Wang Breakdown of academic impact, for papers by Juqian Zhang
Rankless by CCL
2026